Search
Glaukos Corp
GKOSAdd to Watchlist
171.680USD
+0.590+0.34%
Close 09-14 16:00（ET）
10.10BMarket Cap
LossP/E TTM
After-hours 16:10 (ET)171.680USD-0.560-0.33%
After-hours 16:10 (ET)Glaukos Corp (GKOS) Stock Price Target & Forecast
Analyst Rating
Based on 15 analysts giving stock ratings to Glaukos Corp in the past month.
Buy
6 Strong Buy
7 Buy
1 Hold
1 Sell
0 Strong Sell
Target Price
196.167USD+17.29%
GKOS Analyst Recommendation Trends
In the current month, GKOS has received 7 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. GKOS average Analyst price target in the last month is 196.167.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
6
6
6
6
6
6
6
6
7
8
8
8
8
8
8
8
1
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
15
15
16
16
16
16
16
16
GKOS Analyst Rating for Peer Comparison
Updated: Sep 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Dexcom Inc
DXCM
13
13
4
0
0
30
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Abbott Laboratories
ABT
11
12
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
13
2
0
0
27
Insulet Corp
PODD
7
8
12
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Financial Forecasting
Based on analysts' estimates, GKOS EPS is projected to reach -0.094 in FY2026Q3, following reported EPS of -0.312 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.20
-0.27
-0.21
-0.09
0.10
Actual
-2.32
-0.34
-0.31
--
--
Surprise
-1084.52%
-24.99%
-48.29%
--
--
FAQs
What is Glaukos Corp's expected revenue for the next quarter?
Glaukos Corp's expected revenue is 167.92M.
What is Glaukos Corp's price target?
Analysts forecast that Glaukos Corp's price target is USD 196.17, with the highest forecast at USD 225.00 and the lowest forecast at USD 172.00.
How have Glaukos CorpGKOS's recent earnings per share performed?
The market expectation was USD -0.31, while Glaukos CorpGKOS's earnings per share (EPS) for the previous quarter was USD -0.34. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for Glaukos Corp?
Based on the ratings of Glaukos Corp's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.